Healthtech Startups

Hummsa Biotech develops oral small molecule therapeutics targeting chronic metabolic diseases through multi-targeted approaches, aiming to shift treatment from reactive to preventive and regenerative care. The company prioritizes affordability and accessibility across global markets.

1 investor

Grupo Huntington is a reproductive medicine and in vitro fertilization (IVF) clinic group that provides individualized fertility treatments to patients and families in Brazil. It has operated for nearly 30 years, offering assisted reproduction services with psychological support throughout treatment.

1 investor

Suzhou Huihan Medical Technology Development develops and applies biosurgical products for wound repair, orthopedic implants, and tissue engineering, offering surgeons products across hemostasis, surgical sealing, anti-adhesion, and soft tissue management. Founded in 2005, it builds on five proprietary technology platforms—colloidal silver, hydrogel, bacterial cellulose, bio-3D, and metallothionein—and holds over 50 medical device registrations in China.

1 investor

HVR Cardio develops medical devices for cardiovascular applications, drawing on a management team with combined expertise in structural heart technologies and medical device commercialization.

1 investor

Guangdong Hybribio Biotech is a Chinese developer and supplier of nucleic acid molecular diagnostic products, focused on the R&D, production, and sale of molecular diagnostic reagents and instruments, including HPV genotyping detection kits and gene chips. The company also operates a healthcare arm, including a specialty hospital in Chaozhou offering blood purification, health screening, and chronic disease management services.

1 investor

Hydreight Technologies is a publicly traded company (TSXV: NURS) operating in the mobile healthcare space, with offerings that include on-demand nurse-delivered IV therapy and wellness treatments such as semaglutide. This investor relations page covers financial statements, shareholder meeting documents, and press releases.

1 investor

Hydro Gummy makes gummy-based hydration products designed as an alternative to drinking water, targeting consumers of all ages who struggle with traditional hydration methods. The company focuses on making healthy hydration habits more convenient and enjoyable.

1 investor

Hyfe develops an acoustic AI system that detects and continuously monitors cough, establishing cough as a measurable biomarker and clinical endpoint. Its technology serves pharmaceutical companies, medical device manufacturers, academic researchers, and healthcare organizations for clinical trials, digital therapeutics, and consumer cough tracking.

1 investor

Hyfe develops AI-powered cough monitoring technology that continuously and unobtrusively tracks patients' cough patterns over extended periods. Its life sciences offering targets drug development and clinical trials by providing objective, longitudinal cough data.

1 investor

Fantex is a hard surface cleaner formulated to kill up to 99.999% of germs and pathogens within one minute, with residual protection lasting up to 24 hours, suitable for use on all hard surfaces including food preparation areas. The product is tested against international standards and proven effective against bacteria, fungi, and viruses including MRSA, norovirus, and coronavirus.

1 investor

Hygiea is a B2B SaaS platform for healthcare facilities covering hygiene, compliance, and safety operations, including areas such as hand-hygiene compliance and infection control. It targets healthcare providers like nursing homes, clinics, and labs managing regulatory compliance and safety workflows.

1 investor

1 investor

Hylyght provides a platform for collecting, analysing, and reporting data for physiotherapists, doctors, trainers, and coaches, built on sports science research. It is developed in collaboration with research institutions including Ghent University and the Victoris sports innovation consortium.

1 investor

Hyrax Biosciences develops Exatype, a DNA sequence analysis software platform that performs genotyping, quality control, reference mapping, and mutation calling for pathogens including HIV, TB, SARS-CoV-2, and cancer. It serves assay and instrument manufacturers, laboratories, pharmaceutical companies, clinical trial organizations, and research institutions.

1 investor

Hangzhou Bangier Orthopedic Hospital (Hangzhou Linping Orthopedic Hospital), established in 2006, is a national health-insurance-designated orthopedic specialty hospital that emphasizes conservative and minimally invasive treatment. It operates six specialized orthopedic centers covering spine, joint and sports medicine, trauma, hand and foot repair, and pediatric bone development, serving patients in the Linping district of Hangzhou, China.

1 investor

Ikonopedia provides a breast imaging software platform for radiologists and patients, featuring structured reporting tools, risk assessment, and closed-loop lesion tracking to ensure comprehensive breast health management and follow-up care.

1 investor

i-Virtual develops Saphere, a video-based vital sign measurement API that uses remote photoplethysmography (rPPG) and AI to extract health metrics like heart rate, respiratory rate, and stress levels from a 30-second selfie, serving wellness apps, insurtech platforms, and connected device makers.

1 investor

i-BrainTech develops neurofeedback technology that helps athletes improve motor skills, focus, and decision-making through personalized training systems informed by neuroscientific research. The company works with professional football clubs to enhance cognitive and physical performance.

1 investor

i2020 Accelerator (T123 LLC) is a drug discovery accelerator that de-risks early-stage science and advances drug discovery platforms toward lead and clinical candidate stage within roughly two years, working across therapeutic areas such as oncology, immunology, and infectious diseases. It co-creates and invests in biotech startups, operating as part of the Expert Systems integrated accelerator platform.</parameter> <parameter name="hq_city">San Diego

1 investor

i3 develops a hybrid intravascular imaging catheter combining near-infrared fluorescence (NIRF) and ultrasound (IVUS) sensors to provide real-time molecular and structural imaging during coronary interventions. The system enables detection of arterial injury and complications in cardiac catheterization procedures.

1 investor

I Am Mindful develops mental health first-aid toolkits and online resources to teach people coping strategies for managing stress and difficult emotions. The company serves individuals seeking to build proactive mental health skills outside of crisis intervention.

1 investor

Iaso Automated Medical Systems is a medical device company developing machine learning-based technology to detect and manage Acute Respiratory Distress Syndrome (ARDS) in intensive care units. The company helps critical care teams make evidence-based decisions through early warning systems and clinical decision support for critically-ill patients.

1 investor

Ibabaza Media is an IT services and software development company serving businesses in East Africa and Sub-Saharan Africa. The company provides custom software development, mobile app development, website design, IT infrastructure support, social media marketing, and consulting services.

1 investor

IBI SA (Industrie Biomediche Insubri SA) researches, develops, and produces medical devices for tissue engineering and regenerative medicine, including bone substitutes, grafts, 3D matrixes, and 2D scaffolds.

1 investor